{"transactions":[{"id":711127,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-10T22:14:21.000Z","date":"2026-07-09","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.956,"value":48900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.9298 to $1.98. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":461904,"source":{"system":"sec-edgar","filing":"0001493152-26-032884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032884/ownership.xml","form_type":"4"}},{"id":711126,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-10T22:14:21.000Z","date":"2026-07-08","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.9899,"value":39798.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.98 to $2.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":436904,"source":{"system":"sec-edgar","filing":"0001493152-26-032884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032884/ownership.xml","form_type":"4"}},{"id":712549,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-08T22:56:16.000Z","date":"2026-07-07","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":2.0348,"value":61044.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.00 to $2.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":416904,"source":{"system":"sec-edgar","filing":"0001493152-26-032563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032563/ownership.xml","form_type":"4"}},{"id":712548,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-08T22:56:16.000Z","date":"2026-07-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.052,"value":41040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.04 to $2.068. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":386904,"source":{"system":"sec-edgar","filing":"0001493152-26-032563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032563/ownership.xml","form_type":"4"}},{"id":714971,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-06T23:48:29.000Z","date":"2026-07-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.98,"value":19800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.97 to $1.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":366904,"source":{"system":"sec-edgar","filing":"0001493152-26-032229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032229/ownership.xml","form_type":"4"}},{"id":714970,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-06T23:48:29.000Z","date":"2026-07-01","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.98,"value":39600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.97 to $1.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":356904,"source":{"system":"sec-edgar","filing":"0001493152-26-032229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032229/ownership.xml","form_type":"4"}},{"id":731883,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:10:21.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":336904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":336904,"source":{"system":"sec-edgar","filing":"0001493152-26-029329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226029329/ownership.xml","form_type":"4"}},{"id":2056292,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-11T21:10:51.000Z","date":"2023-01-11","kind":"disposition_to_issuer","acquired":false,"shares":11904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."}],"balance_after":0,"derivative":{"exercise_price":15.65,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000899243-23-001585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1536555/000089924323001585/doc4.xml","form_type":"4"}},{"id":2056291,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-11T21:10:51.000Z","date":"2023-01-11","kind":"disposition_to_issuer","acquired":false,"shares":23809,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":23809},"source":{"system":"sec-edgar","filing":"0000899243-23-001585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1536555/000089924323001585/doc4.xml","form_type":"4"}},{"id":2056290,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-11T21:10:51.000Z","date":"2023-01-11","kind":"disposition_to_issuer","acquired":false,"shares":114075,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."}],"balance_after":0,"derivative":{"exercise_price":1.68,"expiration_date":"2030-03-30","underlying":"Common Stock","underlying_shares":114075},"source":{"system":"sec-edgar","filing":"0000899243-23-001585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1536555/000089924323001585/doc4.xml","form_type":"4"}},{"id":2056289,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:10:51.000Z","date":"2023-01-11","kind":"other","acquired":false,"shares":850,"price":36,"value":30600.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-001585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1536555/000089924323001585/doc4.xml","form_type":"4"}},{"id":2104930,"issuer":{"id":122080,"kind":"organization","name":"Frazier Lifesciences Acquisition Corp","symbol":"FLAC"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2022-11-23T21:25:02.000Z","date":"2022-11-22","kind":"exercise","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the terms outlined in the Business Combination Agreement, dated July 25, 2022, by and among NewAmsterdam Pharma Holding B.V., Frazier Lifesciences Acquisition Corporation, NewAmsterdam Pharma Investment Corporation, and NewAmsterdam Pharma Company B.V., these shares were automatically converted into Class A ordinary shares of NewAmsterdam Pharma Company N.V. (Nasdaq symbol \"NAMS\"). The Business Combination closed on November 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms outlined in the Business Combination Agreement, dated July 25, 2022, by and among NewAmsterdam Pharma Holding B.V., Frazier Lifesciences Acquisition Corporation, NewAmsterdam Pharma Investment Corporation, and NewAmsterdam Pharma Company B.V., these shares were automatically converted into Class A ordinary shares of NewAmsterdam Pharma Company N.V. (Nasdaq symbol \"NAMS\"). The Business Combination closed on November 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms outlined in the Business Combination Agreement, dated July 25, 2022, by and among NewAmsterdam Pharma Holding B.V., Frazier Lifesciences Acquisition Corporation, NewAmsterdam Pharma Investment Corporation, and NewAmsterdam Pharma Company B.V., these shares were automatically converted into Class A ordinary shares of NewAmsterdam Pharma Company N.V. (Nasdaq symbol \"NAMS\"). The Business Combination closed on November 22, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms outlined in the Business Combination Agreement, dated July 25, 2022, by and among NewAmsterdam Pharma Holding B.V., Frazier Lifesciences Acquisition Corporation, NewAmsterdam Pharma Investment Corporation, and NewAmsterdam Pharma Company B.V., these shares were automatically converted into Class A ordinary shares of NewAmsterdam Pharma Company N.V. (Nasdaq symbol \"NAMS\"). The Business Combination closed on November 22, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-22-036924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1536555/000089924322036924/doc4.xml","form_type":"4"}},{"id":2243838,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T20:41:09.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual meeting in 2023 of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":11904,"derivative":{"exercise_price":15.65,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0001567619-22-012293","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1536555/000156761922012293/doc1.xml","form_type":"4"}},{"id":2630053,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-19T20:09:15.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":23809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One thirty-sixth (1/36th) of the shares initially subject to the option will vest on each monthly anniversary measured from July 15, 2021 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":23809,"derivative":{"exercise_price":16,"expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":23809},"source":{"system":"sec-edgar","filing":"0001567619-21-013639","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1536555/000156761921013639/doc1.xml","form_type":"4"}},{"id":2630052,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-19T20:09:15.000Z","date":"2021-07-15","kind":"purchase","acquired":true,"shares":850,"price":16,"value":13600.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by Stifel as custodian for the Bob Baltera IRA."}],"balance_after":850,"source":{"system":"sec-edgar","filing":"0001567619-21-013639","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1536555/000156761921013639/doc1.xml","form_type":"4"}},{"id":3859066,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-30T20:51:07.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable in full on the earlier of (i) July 26, 2019 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting."}],"balance_after":45550,"derivative":{"exercise_price":1.29,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":45550},"source":{"system":"sec-edgar","filing":"0001209191-18-044417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919118044417/doc4.xml","form_type":"4"}},{"id":4223474,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-28T20:32:24.000Z","date":"2017-08-24","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable in full on the earlier of (i) August 24, 2018 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting."}],"balance_after":42500,"derivative":{"exercise_price":1.97,"expiration_date":"2027-08-24","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001209191-17-050397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117050397/doc4.xml","form_type":"4"}}]}